These include inactivating NOTCH1 mutations (found in 10–15% of HNSCC) [4], [5], [6], which cluster to the EGF-like binding domain and domains necessary for transactivation of target genes. This evidence concerns the gene EGF and head and neck squamous cell carcinoma.